Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 284.67%4.42M | 35.21%1.15M | 77.40%850.06K | -24.25%479.18K | -34.56%632.53K | 41.08%966.57K | -44.24%685.1K | 58.55%1.23M | 769.54%774.9K | 189.12%89.12K |
| Revenue from customers | 390.91%3.69M | 254.02%751.73K | 69.66%212.34K | 597.79%125.16K | 207.91%17.94K | -50.93%5.83K | -60.00%11.87K | -15.28%29.68K | -60.69%35.03K | --89.12K |
| Income from government grants | ---- | ---- | --25K | ---- | ---- | --113.77K | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | 83.85%731.11K | -35.10%397.66K | 73.08%612.72K | -42.40%354.02K | -27.44%614.6K | 25.81%846.97K | -43.85%673.23K | 62.04%1.2M | 73,987,100.00%739.87K | 100.00%-1 |
| Cash paid | -38.49%-5.14M | -29.01%-3.71M | -20.48%-2.88M | -12.53%-2.39M | 11.29%-2.12M | 24.90%-2.39M | 11.82%-3.19M | -56.23%-3.61M | -58.10%-2.31M | -137.59%-1.46M |
| Payments to suppliers for goods and services | -38.49%-5.14M | -29.01%-3.71M | -20.48%-2.88M | -12.53%-2.39M | 11.29%-2.12M | 24.90%-2.39M | 11.82%-3.19M | -56.23%-3.61M | -58.10%-2.31M | -137.59%-1.46M |
| Direct interest paid | -352.43%-79.23K | 39.58%-17.51K | -242.12%-28.98K | 8.13%-8.47K | -110.31%-9.22K | 76.96%-4.39K | 67.33%-19.04K | -224.71%-58.26K | -557.22%-17.94K | -523.29%-2.73K |
| Direct interest received | -52.06%3.8K | 38.52%7.93K | 466.27%5.73K | -50.34%1.01K | -0.54%2.04K | -71.98%2.05K | 100.47%7.31K | -93.99%3.64K | -3.30%60.66K | 228.11%62.73K |
| Operating cash flow | 69.06%-796.19K | -25.45%-2.57M | -7.00%-2.05M | -28.02%-1.92M | -4.80%-1.5M | 43.15%-1.43M | -3.01%-2.51M | -63.15%-2.44M | -13.82%-1.5M | -88.49%-1.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,015.41%-776.78K | -69.64K | -10.16K | -185.50%-119.11K | 117.40%139.31K | 38.48%-800.43K | 13.65%-1.3M | -1.51M | ||
| Net PPE purchase and sale | -43.40%-272.82K | ---190.25K | ---- | ---10.16K | ---- | ---- | 83.68%-2.14K | 11.20%-13.09K | 68.85%-14.74K | ---47.31K |
| Net intangibles purchas and sale | ---550.93K | ---- | ---- | ---- | ---- | -184.21%-119.11K | 117.97%141.45K | 38.79%-787.35K | -5.18%-1.29M | ---1.22M |
| Net business purchase and sale | --46.98K | ---- | ---- | ---- | ---- | ---- | ---105.94K | ---- | ---- | ---236.42K |
| Net other investing changes | ---- | --120.61K | ---- | ---- | ---- | ---- | ---- | --1 | ---- | ---1 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,015.41%-776.78K | ---69.64K | ---- | ---10.16K | ---- | -185.50%-119.11K | 117.40%139.31K | 38.48%-800.43K | 13.65%-1.3M | ---1.51M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -26.17%1.45M | -39.85%1.97M | 87.43%3.28M | 18.06%1.75M | -12.21%1.48M | -26.16%1.69M | -12.05%2.28M | 446.52%2.6M | -90.74%475K | 219.05%5.13M |
| Net issuance payments of debt | -70.96%402.69K | 356.19%1.39M | -200.04%-541.22K | 342.44%541.02K | -214.09%-223.16K | --195.6K | ---- | ---- | ---- | ---- |
| Net common stock issuance | 75.19%1.31M | -80.34%750.35K | 216.33%3.82M | -29.17%1.21M | 7.40%1.7M | -30.54%1.59M | -12.05%2.28M | 446.52%2.6M | -90.74%475K | 219.05%5.13M |
| Interest paid (cash flow from financing activities) | -51.16%-30.35K | ---20.08K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | -58.44%-232.37K | ---146.67K | ---- | ---- | ---- | ---95.56K | ---- | ---1 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -26.17%1.45M | -39.85%1.97M | 87.43%3.28M | 18.06%1.75M | -12.21%1.48M | -26.16%1.69M | -12.05%2.28M | 446.52%2.6M | -90.74%475K | 219.05%5.13M |
| Net cash flow | ||||||||||
| Beginning cash position | -49.70%652.91K | 1,658.65%1.3M | -70.88%73.81K | -6.38%253.42K | 40.50%270.68K | -33.15%192.65K | -68.77%288.2K | -71.57%922.75K | 246.09%3.25M | 3,312.70%937.78K |
| Current changes in cash | 82.39%-118.44K | -154.95%-672.64K | 781.57%1.22M | -940.67%-179.61K | -112.50%-17.26K | 252.05%138.02K | 85.91%-90.77K | 72.24%-644.39K | -200.60%-2.32M | 153.52%2.31M |
| Effect of exchange rate changes | -33.33%18.36K | 65,476.19%27.54K | --42 | ---- | ---- | ---- | -148.50%-4.77K | 860.43%9.84K | ---1.29K | ---- |
| End cash Position | -15.33%552.83K | -49.70%652.91K | 1,658.65%1.3M | -70.88%73.81K | -23.36%253.42K | 71.64%330.68K | -33.15%192.65K | -68.77%288.2K | -71.57%922.75K | 246.09%3.25M |
| Free cash from | 41.38%-1.62M | -34.73%-2.76M | -6.44%-2.05M | -28.69%-1.93M | 3.26%-1.5M | 38.41%-1.55M | 22.44%-2.51M | -15.87%-3.24M | -8.22%-2.8M | -270.70%-2.58M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |